Jeong Heo

22PUBLICATIONS
110CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsHaematological tumoursNeural engineeringTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 09, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

|Apr 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon, Alejandra Villamil, Ira M Jacobson

|Feb 26, 2026
Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.

Palaniyandi Muthukutty, Jeong Heo, So Young Yoo

|Nov 07, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin

|Aug 14, 2024
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC.

Ho Yeong Lim, Jeong Heo, Julio A Peguero

Pageof 4